🇺🇸 APO-clonidine in United States

27 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Weight Increased — 4 reports (14.81%)
  2. Arthralgia — 3 reports (11.11%)
  3. Fall — 3 reports (11.11%)
  4. Fatigue — 3 reports (11.11%)
  5. Headache — 3 reports (11.11%)
  6. Vomiting — 3 reports (11.11%)
  7. Asthenia — 2 reports (7.41%)
  8. Death — 2 reports (7.41%)
  9. Diarrhoea — 2 reports (7.41%)
  10. Drug Ineffective — 2 reports (7.41%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is APO-clonidine approved in United States?

APO-clonidine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for APO-clonidine in United States?

University Health Network, Toronto is the originator. The local marketing authorisation holder may differ — check the official source linked above.